In Depth 4 Feb 2025
World Cancer Day: trends in cancer therapeutics to look forward to in 2025
As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer care in 2025.
Immunotherapy
- Latest Posts
In Depth 17 Jan 2025
Are PD-1 and PD-L1 checkpoint inhibitors as good as we thought?
Checkpoint inhibitors, especially those targeting PD-1 and PD-L1, are exploding in popularity. But how much of it is hype?
Best in Biotech 30 Dec 2024
Six biotech companies leading the way in India
Discover six of the top biotech companies in India, which is currently brimming with biotechs and a young, skilled workforce.
In Depth 17 Dec 2024
Ovarian cancer: BioNTech, Curelab, OvarianVax and more bring vaccines to the clinic
A number of ovarian cancer vaccines are being evaluated including the world’s first cancer prevention vaccine, which recently received funding.
In Depth 11 Dec 2024
Targeting sugar molecules: Can glycobiology lead to a new era for cancer immunotherapy?
Find out more about the emerging field of glycobiology, which could potentially lead to a new type of cancer immunotherapy.
In Depth 2 Dec 2024
The rise of cancer vaccines: A new era in immunotherapy
Delve into the expanding and diverse field of cancer vaccines with various approaches exploiting the immune system to fight tumors.
ADVERTISEMENT
ADVERTISEMENT
Best in Biotech 31 Oct 2024
Five T cell engager companies you should know about
Discover five T cell engager companies that have emerged in recent times, as this class of therapeutics is set to take off.
In Depth 30 Oct 2024
Spatial Transcriptomics: A window into disease
The emerging spatial transcriptomics field is letting researchers map out gene expression in tumor and brain samples. How could this change the way we treat disease?
In Depth 30 Oct 2024
Could next-generation “switchable” CAR-T cells help improve the safety and efficacy of CAR-T therapies?
Discover how next-generation “switchable” CAR-T cells could improve both the safety and efficacy of CAR-T therapies.
In Depth 18 Sep 2024
Two targets, one solution: The rise of bispecific antibodies
Find out all you need to know about bispecific antibodies, including how they work and what the current clinical landscape looks like.
News and Trends 16 Sep 2024
Vironexis’ AAV vector approach: The next frontier in cancer immunology?
Delve into Vironexis’ launch with a pipeline of 10 cancer drug candidates built around its AAV vectors platform.
News and Trends 4 Sep 2024
2024: a year of breakthroughs for endometrial cancer?
New treatments have been approved by regulators for endometrial cancer, which are regarded as major therapeutic breakthroughs.
ADVERTISEMENT
